HKHajar Khattab

Hajar Khattab

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hajar Khattab has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Asmae Sikkal

    Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco

    3 shared publications
  • Bouchra El Moutawakil

    Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco; Laboratory of Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, Casablanca, Morocco

    3 shared publications
  • Hicham El Otmani

    Neurology Department, Ibn Rochd University Hospital Center, Casablanca, Morocco

    3 shared publications
  • Kamal Haddouali

    Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco

    3 shared publications
  • Mohamed Abdoh Rafai

    Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco; Research Laboratory on Nervous System Diseases, Neurosensory Diseases and Disability, Faculty of Medicine and Pharmacy, Casablanca, Morocco

    3 shared publications
  • Salma Bellakhdar

    Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco; Laboratory of Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, Casablanca, Morocco

    3 shared publications

Latest Publications

  • Economic and social burden of multiple sclerosis in Morocco: a tertiary care center study

    by Hicham El Otmani, Kaoutar Simma, Hajar El Omari, Asmae Sikkal, Hajar Khattab, Kamal Haddouali, Salma Bellakhdar, Bouchra El Moutawakil, Mohamed Abdoh Rafai

  • Open Access

    Paroxysmal motor signs in multiple sclerosis: an illustrative videotaped case

    by Ghita Lahmam, Asmae Sikkal, Hajar Khattab, Kamal Haddouali, Salma Bellakhdar, Bouchra El Moutawakil, Mohamed Abdoh Rafai, Hicham El Otmani

    Multiple sclerosis (MS) presents with a wide spectrum of neurological manifestations, among which paroxysmal motor phenomena remain a diagnostic and therapeutic challenge. We report the case of a 29-year-old male diagnosed with relapsing–remitting MS (RRMS) who exhibited episodes of paroxysmal dystonia, dysarthria-ataxia, and ptosis. Brain MRI revealed multiple demyelinating plaques, including a contrast-enhancing lesion in the right midbrain, which provides an anatomical correlation with the patient's neurological manifestation. The dystonic movements resolved with corticosteroid therapy, while symptomatic management with carbamazepine was required for dysarthria-ataxia. Ocrelizumab has been proposed as a long-term disease-modifying treatment. This case highlights the importance of recognizing paroxysmal motor signs in MS for early diagnosis and tailored management, despite their elusive pathogenesis.

  • Open Access

    Paraneoplastic progressive Supranuclear palsy: a case report and literature review

    by Kaoutar Simma, Asmae Sikkal, Hajar Khattab, Kamal Haddouali, Salma Bellakhdar, Bouchra EL Moutawakil, Mohamed Abdoh Rafai, Hicham EL Otmani

    Progressive supranuclear palsy-Richardson syndrome (PSP-RS) is a sporadic atypical parkinsonian disorder typically resistant to levodopa. While most cases are neurodegenerative, various conditions (genetic, vascular, infectious, or paraneoplastic) can mimic this phenotype, termed PSP-like or PSP mimics. Although paraneoplastic PSP is extremely rare, it is important to recognize because of its potential reversibility. The diagnosis can be particularly challenging, especially when classical tumor markers or imaging fail to identify a clear neoplastic origin. Here, we describe a 39-year-old man with an Anti-Ri–mediated PSP-like syndrome in whom an extensive evaluation, including surgical removal of two suspicious sites (thymus and testis), failed to identify an underlying tumor. The patient presented with rapidly progressive symptoms characteristic of PSP-RS, raising clinical suspicion for a paraneoplastic cause. We also review the literature on paraneoplastic PSP.